Introduction Since its emergence, there have been huge efforts to design vaccines against
coronavirus disease 2019 (COVID-19) to inhibit its interpersonal spread. Global vaccine …

Objective: Unknown etiology Background: Since December 2020, multiple vaccines have
mobilized mass immunization campaigns capable of mitigating the current SARS-COV-2 …

Guillain-Barré syndrome (GBS) is an acute inflammatory polyradiculoneuropathy. In two-
thirds of patients, it is preceded by an upper respiratory or gastrointestinal tract infection …

Vaccinations against the severe acute respiratory syndrome coronavirus 2 which causes
COVID‐19 have been administered worldwide. We aimed to investigate associations of …

In this article we review complications to the peripheral nervous system that occur as a
consequence of viral infections, with a special focus on complications of severe acute …

Abstract Background and purpose Guillain-Barré-Syndrome (GBS) can follow COVID-19
vaccination, with clinical and paraclinical features still to be precisely assessed. We describe …

Cerebral venous thrombosis (CVT), a rare thrombotic event that can cause serious
neurologic deficits, has been reported after some ChAdOx1 nCoV-19 vaccinations against …

Objective The coronavirus disease 2019 (COVID-19) vaccination coverage, willingness, and
safety profiles in patients with epilepsy remain poorly understood. We aimed to summarize …

Abstract Introduction/Aims We aimed to determine whether specific severe acute respiratory
syndrome coronavirus 2 (SARS‐CoV2) vaccines may be associated with acute‐onset …

Objective To investigate the association between Guillain-Barré syndrome (GBS) and
COVID-19 vaccination. Background On July 13, 2021, the US Food and Drug Administration …